Advances in the Treatment of Triple-negative Early Breast Cancer.
about
A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancersComparison of Two Components of Propolis: Caffeic Acid (CA) and Caffeic Acid Phenethyl Ester (CAPE) Induce Apoptosis and Cell Cycle Arrest of Breast Cancer Cells MDA-MB-231.PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis.
P2860
Advances in the Treatment of Triple-negative Early Breast Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Advances in the Treatment of Triple-negative Early Breast Cancer.
@en
type
label
Advances in the Treatment of Triple-negative Early Breast Cancer.
@en
prefLabel
Advances in the Treatment of Triple-negative Early Breast Cancer.
@en
P2093
P50
P1433
P1476
Advances in the Treatment of Triple-negative Early Breast Cancer
@en
P2093
Federica D'Aurizio
Giovanni M Fadda
Renato Tozzoli
P304
P356
10.2174/1573406412666151116144026
P577
2016-01-01T00:00:00Z